Medtronic expands cath lab tools by acquiring CathWorks for $585 million, enhancing its interventional cardiology portfolio with AI technology.

Medtronic (NYSE:MDT) announced today that it exercised its option to acquire coronary artery disease (CAD) tech developer ...

Cutting edge imaging, rapid PCI protocols, and patient centered follow up improving outcomes for acute coronary syndromes.

The purchase will give Medtronic a larger presence in the cath lab, with a tool to help diagnose and treat coronary artery ...

In its announcement, Medtronic said it plans to move forward with the CathWorks acquisition in a transaction valued at up to ...

Medtronic has agreed to acquire the medical device company CathWorks in a deal valued up to $585 million. The healthcare technology company said Tuesday that it had exercised an option to acquire the ...

Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...

As interventional cardiology has evolved, Roxborough Memorial Hospital is committed to providing state-of-the-art care in its ...